Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06367894
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-04-11
Brief Title:
Treatment Optimization and Nephrolithiasis Recurrence Prevention With Interdisciplinary Care
Sponsor:
Agnieszka Pozdzik
Organization:
Brugmann University Hospital
Study Overview
Official Title:
Study on Treatment Optimization and Nephrolithiasis Recurrence Prevention With Interdisciplinary Care
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Nearly 10 of the Belgian population suffer from kidney stone disease Recent reviews reported that kidney stones represent an underestimated risk factor for further kidney function deterioration Preventive measures are recommended in lithiases patients to prevent the formation of new stones The individual effects of different medicated prosthetic interventions have been documented in clinical trials However there is little data on the effectiveness of combining these different preventive measures in routine clinical practice real-world context
Patients with kidney stone disease require a complete metabolic assessment The three main factors contributing to the stones formation are the patients metabolism diet and lifestyle Metabolic work-up is recommended by the American Urology Association to identify and correct the factors responsible for urinary stone formation such as hypercalciuria hyperoxaluria hyperuricuria hypocitraturia or abnormalities of urinary pH The metabolic work-up includes at minimum the 24h urine test a blood test and spot urine test Dietary habits and lifestyle are assessed by means of a questionnaire
The CHU Brugmann Hospital has a specialized multidisciplinary clinic for renal lithiases and mineral metabolism Preventive personalized and interdisciplinary care in CHU Brugmann consists of a full metabolic work-up allowing the identification of lithogenic risk factors by nephrologists dietary assessment by specialized dieticians and specific treatment protocol associated with regular follow-up
The aim of this study is to evaluate in the context of a retrospective single-center cohort study the effect of preventive personalized and interdisciplinary care on the evolution of all urinary lithogenic risk factors and the recurrence of kidney stones rate of renal colics emergency room admissions and urological interventions
Patients with kidney stone disease require a complete metabolic assessment The three main factors contributing to the stones formation are the patients metabolism diet and lifestyle Metabolic work-up is recommended by the American Urology Association to identify and correct the factors responsible for urinary stone formation such as hypercalciuria hyperoxaluria hyperuricuria hypocitraturia or abnormalities of urinary pH The metabolic work-up includes at minimum the 24h urine test a blood test and spot urine test Dietary habits and lifestyle are assessed by means of a questionnaire
The CHU Brugmann Hospital has a specialized multidisciplinary clinic for renal lithiases and mineral metabolism Preventive personalized and interdisciplinary care in CHU Brugmann consists of a full metabolic work-up allowing the identification of lithogenic risk factors by nephrologists dietary assessment by specialized dieticians and specific treatment protocol associated with regular follow-up
The aim of this study is to evaluate in the context of a retrospective single-center cohort study the effect of preventive personalized and interdisciplinary care on the evolution of all urinary lithogenic risk factors and the recurrence of kidney stones rate of renal colics emergency room admissions and urological interventions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None